This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Olatoye A. Agbato, MD; Abdulmajid A. Elyas; Philip N. Patsalos, PhD; Edward M. Brett, DM; Peter T. Lascelles, MD

Arch Neurol. 1986;43(11):1111-1116.

Abstract
• Simultaneous steady-state serum total and free (non-protein-bound) concentrations of carbamazepine and carbamazepine-10,11-epoxide were measured in 68 patients under the age of 21 years with epilepsy (44 males, 24 females; mean age, 11.8 4.5 years). Thirty patients were maintained on monotherapy with carbamazepine. Mean serum total carbamazepine and carbamazepine10,11-epoxide concentrations obtained were 7.0 2.4 mg/L (29.5 10.0 µmol/ L) and 1.5 0.6 mg/L (5.9 2.6 µmol/ L), respectively. Mean serum-free carbamazepine and carbamazepine-10,11-epoxide concentrations obtained were 1.3 0.5 mg/L (5.7 2.1 µmol/L) and 0.5 0.3 mg/L (2.2 1.1 µmol/L), respectively. Binding of carbamazepine and carbamazepine-10,11-epoxide was 81% 3% and 62% 10%, respectively. There was no significant difference in binding between male and female patients or those maintained on monotherapy and polytherapy. Age correlated significantly with carbamazepine binding but not with carbamazepine-10,11-epoxide binding. Free concentrations of carbamazepine and carbamazepine-10,11-epoxide correlated significantly with total carbamazepine and total carbamazepine10,11-epoxide concentrations, respectively, indicating that the binding capacities of both carbamazepine and carbamazepine-10,11-epoxide are constant at serum total carbamazepine concentrations within the quoted therapeutic range.

Author Affiliations
From the Department of Neurology, The Hospital for Sick Children, London (Drs Agbato and Brett), the Department of Chemical Pathology, The National Hospital for Nervous Diseases, London (Mr Elyas and Drs Patsalos, and Lascelles), and The Chalfont Centre for Epilepsy, Chalfont St Peter, Buckinghamshire (Dr Patsalos).

Footnotes
Accepted for publication Dec 6, 1985.

Reprint requests to the Department of Chemical Pathology, The National Hospital, Queen Square, London WC1N 3BG, England (Dr Patsalos).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?